158 related articles for article (PubMed ID: 36406309)
21. Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt.
Sturm L; Praktiknjo M; Bettinger D; Huber JP; Volkwein L; Schmidt A; Kaeser R; Chang J; Jansen C; Meyer C; Thomas D; Thimme R; Trebicka J; Schultheiß M
Hepatol Commun; 2021 Apr; 5(4):650-660. PubMed ID: 33860123
[TBL] [Abstract][Full Text] [Related]
22. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
23. Novel CABIN score outperforms other prognostic models in predicting in-hospital mortality after salvage transjugular intrahepatic portosystemic shunting.
Krige J; Jonas E; Robinson C; Beningfield S; Kotze U; Bernon M; Burmeister S; Kloppers C
World J Gastrointest Pathophysiol; 2023 Mar; 14(2):34-45. PubMed ID: 37035274
[TBL] [Abstract][Full Text] [Related]
24. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
[TBL] [Abstract][Full Text] [Related]
25. Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment.
Alessandria C; Gaia S; Marzano A; Venon WD; Fadda M; Rizzetto M
Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):607-12. PubMed ID: 15167164
[TBL] [Abstract][Full Text] [Related]
26. Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.
Zhang F; Zhuge Y; Zou X; Zhang M; Peng C; Li Z; Wang T
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):853-60. PubMed ID: 24915489
[TBL] [Abstract][Full Text] [Related]
27. Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review.
Zhou C; Hou C; Cheng D; Tang W; Lv W
Int J Clin Exp Med; 2015; 8(8):13464-72. PubMed ID: 26550283
[TBL] [Abstract][Full Text] [Related]
28. Within-patient temporal variance in MELD score and impact on survival prediction after TIPS creation.
Gaba RC; Shah KD; Couture PM; Parvinian A; Minocha J; Knuttinen MG; Bui JT
Ann Hepatol; 2013; 12(5):797-802. PubMed ID: 24018498
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
[TBL] [Abstract][Full Text] [Related]
30. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.
King A; Masterton G; Gunson B; Olliff S; Redhead D; Mangat K; Oniscu G; Hayes P; Tripathi D
Liver Transpl; 2011 Jul; 17(7):771-8. PubMed ID: 21714062
[TBL] [Abstract][Full Text] [Related]
31. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
Walter A; Rudler M; Olivas P; Moga L; Trépo E; Robic MA; Ollivier-Hourmand I; Baiges A; Sutter O; Bouzbib C; Peron JM; Le Pennec V; Ganne-Carrié N; Garcia-Pagán JC; Mallet M; Larrue H; Dao T; Thabut D; Hernández-Gea V; Nault JC; Bureau C; Allaire M;
Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
[TBL] [Abstract][Full Text] [Related]
32. Development of a new Cox model for predicting long-term survival in hepatitis cirrhosis patients underwent transjugular intrahepatic portosystemic shunts.
Lv YF; Zhu B; Meng MM; Wu YF; Dong CB; Zhang Y; Liu BW; You SL; Lv S; Yang YP; Liu FQ
World J Gastrointest Surg; 2024 Feb; 16(2):491-502. PubMed ID: 38463355
[TBL] [Abstract][Full Text] [Related]
33. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
34. Predictors of mortality after transjugular portosystemic shunt.
Ascha M; Abuqayyas S; Hanouneh I; Alkukhun L; Sands M; Dweik RA; Tonelli AR
World J Hepatol; 2016 Apr; 8(11):520-9. PubMed ID: 27099653
[TBL] [Abstract][Full Text] [Related]
35. A modified model for predicting mortality after transjugular intrahepatic portosystemic shunt: A multicentre study.
Zhao Y; Yang Y; Lv W; Zhu S; Chen X; Wang T; Huang M; An T; Duan C; Yu X; Li Q; Chen J; Luo J; Zhou S; Lu L; Huang M; Fu S
Liver Int; 2024 Feb; 44(2):472-482. PubMed ID: 38010919
[TBL] [Abstract][Full Text] [Related]
36. Preoperative TIPS and in-hospital mortality in patients with cirrhosis undergoing surgery.
Piecha F; Vonderlin J; Frühhaber F; Graß JK; Ozga AK; Harberts A; Benten D; Hübener P; Reeh M; Riedel C; Bannas P; Izbicki JR; Adam G; Huber S; Lohse AW; Kluwe J
JHEP Rep; 2024 Jan; 6(1):100914. PubMed ID: 38074512
[TBL] [Abstract][Full Text] [Related]
37. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.
Parvinian A; Shah KD; Couture PM; Minocha J; Knuttinen MG; Bui JT; Gaba RC
J Vasc Interv Radiol; 2013 Jul; 24(7):941-6. PubMed ID: 23707226
[TBL] [Abstract][Full Text] [Related]
38. Impact of transjugular intrahepatic portosystemic shunt creation on intermediate-term model for end-stage liver disease score progression.
Casadaban LC; Gabra MG; Parvinian A; Minocha J; Knuttinen MG; Bui JT; Gaba RC
Transplant Proc; 2014 Jun; 46(5):1384-8. PubMed ID: 24935301
[TBL] [Abstract][Full Text] [Related]
39. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
[TBL] [Abstract][Full Text] [Related]
40. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
